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Abstract
Introduction: A number of patients are excluded from electrical stimulation treatment because there is concern that
electrical stimulation could cause electromagnetic interference with pacemakers and implanted cardioverter defibrillators.
The decision to use electrical stimulation in these patients needs to be supported by an assessment of benefit and harm.
Methods: We conducted a systematic review of the risk of electromagnetic interference between electrical stimulation
and pacemakers or implanted cardioverter defibrillators. We included the electronic databases MEDLINE and EMBASE in
the time period between 1966 and 26 August 2016.
Results: 18 papers fulfilled the inclusion criteria (eight safety studies and ten case studies). Although we were unable to
accurately estimate the risk of electromagnetic interference, the studies revealed that patients having electrical stimula-
tion of the lower limb are less susceptible to electromagnetic interference.
Conclusions: The results suggest that electrical stimulation could be used safely to help drop foot in patients with
pacemakers or implanted cardioverter defibrillators. However, in order to obtain an accurate estimate of the risk of
electromagnetic interference, a large, long-term, and intervention-specific safety study is required. Until such a study is
undertaken, electrical stimulation should be used with caution in patients with pacemakers and implanted cardioverter
defibrillators.
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Introduction
Drop foot is a major cause of disability. It is estimated
that over 20% of stroke survivors have drop foot, as
well as many patients with multiple sclerosis, incom-
plete spinal cord injury, and traumatic brain injury.1
Several diﬀerent types of electrical stimulation (ES)
can be used to treat motor dysfunction and pain.
Functional electrical stimulation (FES), neuromuscular
electric stimulation (NMES), and transcutaneous elec-
tric nerve stimulation (TENS) all deliver a current to
muscles through electrodes. FES and NMES are func-
tional interventions which use frequencies of 20–50Hz
in order to produce muscle tetany and a ‘functional’
contraction, whereas TENS is a therapeutic interven-
tion, usually administered either at low frequencies (2–
10Hz) and high amplitude, or high frequencies
(100Hz) and low amplitude, which does not activate
motor ﬁbres.
FES is commonly used as an orthosis for drop foot.
It has been shown to increase walking safety, speed,
range, and independence, as well as reduce the eﬀort
of walking.2–4 However, it is relatively common for
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people with drop foot to have a pacemaker or
implanted cardioverter deﬁbrillator (ICD) and there is
concern that applying FES could cause electromagnetic
interference (EMI). Patients with pacemakers and ICDs
are generally advised to avoid exposure to electrical
currents and electromagnetic sources such as ES
because EMI can lead to pacemaker and ICD malfunc-
tion, resulting in failure to detect arrhythmia or misin-
terpretation of EMI as a shockable arrhythmia.5
Modern pacemakers and ICDs are generally placed in
a pectoral position and connected to one or two transve-
nous bipolar endocardial leads. Modern ICDs have
pacing capabilities and many ICD patients have concur-
rent indication for cardiac pacing. What distinguishes an
ICD from a pacemaker is the presence of a deﬁbrillation
electrode (generally combined on one transvenous lead
with the pacing/sensing electrodes). All modern pace-
makers sense the activity of the heart and pace when
the intrinsic electrical activity of the heart rate falls
below a programmed rate. Most patients are managed
with one of three pacing modes: AAI (atrium paced,
atrium sensed, pacemaker inhibited), VVI (ventricle
paced, ventricle sensed, pacemaker inhibited), or DDD
(both chambers paced, both chambers sensed, pacemaker
triggered or inhibited). For further information on pace-
maker nomenclature and selection, see Bernstein et al.6
Contemporary ICDs also have several options for
arrhythmia detection and treatment.
The use of bipolar leads and improved sensing algo-
rithms in pacemakers and ICDs are thought to have
reduced the chance of EMI. However, the exact risk
and what determines interaction between ES and
modern pacemakers/ICDs is unknown. Therefore, stu-
dies investigating the beneﬁts of FES for drop foot have
excluded patients with pacemakers and ICDs because
of the risk of EMI.2–4 A detailed evaluation of the
determinants and likelihood of harm as a result of
device interaction is required to help clinicians decide
whether or not to start treatment.
Methods
We systematically reviewed the scientiﬁc literature
including MEDLINE and EMBASE (in the time
period between 1966 and 26 August 2016) to identify
reports of pacemaker and ICD adverse events asso-
ciated with ES. The search strategy was developed in
conjunction with a Clinical Librarian. We searched
using the free-text terms ‘functional electrical stimula-
tion’, ‘FES’, ‘neuromuscular stimulation’, ‘NMES’,
‘electrical stimulation’, ‘transcutaneous electrical nerve
stimulation’, ‘TENS’, ‘pacemaker’, ‘deﬁbrillator’,
‘implanted cardioverter deﬁbrillator’, ‘ICD’. Studies
were deemed eligible for inclusion if they were original
articles/safety studies or case reports on the topic of
FES, NMES, or TENS in patients with a pacemaker
or ICD. Author searches for key experts in the ﬁeld
were conducted and the references cited in relevant
papers were considered for inclusion. Only studies
with a full text available in English were included.
Results
A total of 951 publications were identiﬁed using the
search strategy and then screened for eligibility by
title and abstract. Nine hundred and thirty-two articles
were rejected based on their title and abstract as they
were unrelated, duplicates or the full text was not avail-
able in English. Seventeen publications were selected to
be read in full (see Figure 1) and these consisted of eight
safety studies and nine case studies. One advance online
publication was identiﬁed by personal communication.
The safety studies and case studies are summarised in
tables 1 and 2, respectively.
Safety studies
Crevenna et al.7 performed a safety study in eight clin-
ically stable subpectoral ICD patients (implanted >6
months ago) with transvenous bipolar sensing leads.
They sought to identify whether they could induce
EMI by changing the stimulation algorithm and the
951 publications identified 
through database searching
397 MEDLINE
554 EMBASE
19 full-text articles assessed 
for eleigibility
9 MEDLINE
10 EMBASE
17 publications included 
8 MEDLINE
9 EMBASE
1 unable to find full text 
article
1 full text not in English
932 results excluded as did 
not meet selection criteria
4 results exluded as 
duplicates
Figure 1. Study flow diagram.
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location of the electrodes. The following therapeutic
electrical stimulation algorithms were applied to the
neck and shoulder:
1. Impulse galvanisation (IG50: an amplitude-modu-
lated direct current impulse with a frequency of
200Hz, an impulse duration of 400 ms, and a
serial duration of 50ms).
2. Frequency modulation (FM: individual impulses
with a frequency of 3.33–33.3Hz and an impulse
duration of 400ms alternated by tetanising impulse
eﬀects)
3. High-frequency transcutaneous electrical nerve
stimulation (narrow rectangular impulses of 200 ms
at a frequency of 100Hz)
4. Low-frequency transcutaneous electrical nerve
stimulation (LF-TENS: narrow rectangular impulses
of 200ms at a frequency of approximately 2Hz).
The following functional interventions were applied
to the thigh muscles:
1. ‘E200’ (impulses of a rising ramp of 200ms and
pulse duration of 270ms at a frequency of 0.44Hz)
2. ‘aS’ (pulse duration of 400 ms with a threshold dur-
ationofapproximately6.5 sata frequencyof66.7Hz)
3. ‘aS1’ (pulse duration of 400ms and a threshold dur-
ation of 3.6Hz at a frequency of 66.7Hz)
4. ‘FIB’ which is a specially programmed current that
mimics tachycardia (triangular impulses over 60ms
with an interval of 200ms).
Two home therapy NMES devices for stimulating
muscles were also tested:
1. Stiwell 1200 (biphasic symmetric constant voltage
impulses of 500 ms pulse width at a frequency of
15Hz over 2 s)
2. Compex 2 (biphasic, symmetric, constant voltage
impulses of 250 ms pulse width at a frequency of 8,
15, 30, and 50Hz and a rising ramp of 1 s, steady
impulse over 8 s, and 1 s falling ramp).
The ICD was interrogated for EMI following each
stimulation algorithm at the highest tolerable current.
EMI of atrial sensing was detected in one patient
during FM of the neck and two patients during
TENS of the neck. EMI of ventricular sensing was
detected in one patient during FM and two patients
during LF-TENS. EMI was detected as ventricular
under-sensing in two patients during FIB. None of
the EMI detected fulﬁlled ICD detection criteria for a
tachyarrhythmic ventricular episode. The authors sug-
gest that a safety procedure to look for EMI is needed
before starting ES in patients with ICDs.
In a diﬀerent study, Crevenna et al.8 assessed the
safety of NMES of the thigh muscles in seven patients
with chronic heart failure and pacemakers (>6 months
post-implantation) with bipolar sensing leads (VVI and
DDD) over a series of 20 sessions lasting 40min for
strength and endurance training. The impulses were
biphasic, symmetric, and rectangular. The pulse width
was kept at 250 ms, but frequency was adjusted between
8 and 50Hz and current was increased up to 100mA in
all patients. No adverse eﬀects were detected during the
safety procedure (which involved applying NMES
under electrocardiogram (ECG) monitoring) or
during subsequent sessions (which involved heart rate
monitoring). They suggest that, after a safety proced-
ure, NMES of the thigh is safe in patients with pace-
makers. They recommend maximum burst duration of
3 s because if the stimulation causes the heart to pause,
pre-syncope/syncope is only likely to occur after 3 s.
Crevenna et al.9 also carried out a safety study to test
long-term NMES of the thigh in clinically stable
patients with subpectoral ICDs (>6 months post-
implantation) for increasing muscle strength and endur-
ance capacity. Two outpatients had NMES for 4 h daily
over 12 weeks (biphasic, symmetric pulses of 500 ms,
pulse width at 15Hz, 2 s on 4 s oﬀ), and four inpatients
had up to sixteen 30min sessions during their stay
(biphasic, symmetric pulses with duration of 400 ms at
63.3Hz, 3.5 s on, 4.5 s oﬀ). ICD interrogation showed
no abnormal rhythm detection after an initial super-
vised stimulation session. There were no adverse
events in the long term. They conclude that NMES of
the thigh seems to be safe in the long term.
Eriksson et al.10 studied TENS at the thoracic, para-
vertebral, lumbar-sciatic, and distal lower extremity
levels in eight patients with diﬀerent types of pacemaker
(four with ventricular inhibited, one with ventricular
triggered, one with atrial triggered, and two with asyn-
chronous). They monitored patients for blocking of the
pacemaker using a surface ECG whilst changing the
current and frequency of stimulation (constant current
stimulator with 200ms square pulses at a frequency of
10–100Hz in short trains between 1 and 10Hz and up
to 40mA). They found that the four ventricular-inhib-
ited pacemakers were blocked with 1–6Hz and up to
10mA in the thoracic, paravertebral, and lumbar-scia-
tic positions but not in the lower extremity. The ven-
tricular-triggered pacemaker was aﬀected by
frequencies above 2Hz, which corresponds to a heart
rate of up to 130/min, the upper limit for the
pacemaker. The atrial synchronous pacemaker was
triggered by stimulation up to the maximal rate of
150/min. The two asynchronous pacemakers were not
blocked or triggered by the stimulator because these
pacemakers have no sensing capability. The authors
suggest that TENS is contraindicated in synchronous
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pacemakers but TENS can be given without risk to
those with asynchronous pacemakers. An asynchron-
ous mode is often used in patients undergoing surgical
procedures because electrocautery can cause EMI with
synchronous pacemakers. It can also be used as a
backup mode if a synchronous pacemaker’s ability to
sense is deactivated. However, asynchronous pacing
modes are rarely used long term because they can be
associated with competition between the physiologic
and paced rhythm.
Holmgren et al.11 studied TENS at the mamilla and
hip levels in patients with an ICD. The stimulator deliv-
ered an asymmetric biphasic current-compensated
pulse with duration of 180 ms and the amplitude set at
the highest comfortable level. The high-frequency set-
ting delivers continuous impulses at 80Hz whereas the
low-frequency setting delivers impulses in 2Hz bursts
as a train of eight impulses. A surface ECG, intracar-
diac electrogram, and ICD marker channel were
monitored continuously. EMI of the ICD sensing func-
tion was detected during all attempts, resulting in
inappropriate interpretation of ventricular ﬁbrillation
(VF)/ventricular tachycardia (VT) in eight patients
(27%) and premature ventricular beats in 14 patients
(47%). EMI was interpreted as noise in two patients
and under-sensing in two patients. They found that
EMI occurred more frequently in patients with inte-
grated, rather than bipolar leads; at the mamilla,
rather than the hip level; and at 80Hz, rather than
2Hz. The authors suggest that TENS should not be
recommended for any ICD patients.
Iwatsu et al.12 sought to determine the feasibility of
NMES of the thigh following cardiovascular surgery.
Sixty-one patients had 60min NMES sessions, and 10
of these patients were having temporary epicardial
pacing at the time of their ﬁrst NMES session.
Frequency was varied between 20 and 200Hz, the
waveform was symmetric and biphasic. The current
was delivered for 0.4 s followed by a 0.6 s pause. Pulse
groups consisted of 10 impulse trains delivered at 30 s
intervals. Pulse width was 400 ms and current was varied
according to muscle response. They looked at several
outcome measures: compliance, systolic blood pressure,
heart rate, and the incidence of pacemaker malfunction
during NMES. They identiﬁed no pacemaker malfunc-
tion in response to NMES and no excessive changes in
the other outcome measures. They suggest that NMES
is safe in patients after cardiovascular surgery.
Kamiya et al.13 studied NMES of the lower limb in
27 heart failure patients with pectoral ICDs hospita-
lised for decompensation. Knee ﬂexors and calf muscles
were stimulated for 20min with burst-modulated stimu-
lation (alternating sinusoidal current (2.5 kHz) in bursts
with a carrier frequency of 50Hz at the highest intensity
tolerable, 5 s on 5 s oﬀ). Patients were monitored with a
continuous intracardiac electrocardiography and a
surface ECG. EMI was deﬁned as over-sensing,
inappropriate tachycardia detection, or reprogramming
of the device. There was no evidence of EMI through-
out the study.
Wiesinger et al.14 performed a safety study investi-
gating NMES of knee extensor muscles in four men
with chronic heart failure awaiting a transplantation
and implanted bipolar dual-chamber pacemakers
(DDD) due to bradyarrhythmias. A stimulation
exercise programme was applied for 20min under con-
tinuous ECG. The NMES protocol consisted of bipha-
sic, symmetric, constant voltage impulses of 700 ms
pulse width at a frequency of 50Hz, 2 s on and 6 s
oﬀ. Pacemakers were then checked for changes in the
programmed parameters. No clinical adverse eﬀects
were noted on the ECG or on pacemaker check. The
authors suggest that, after a safety protocol, NMES of
the knee extensor muscles is safe in patients with bipo-
lar DDD pacemakers, but long-term safety data are
needed.
Case studies
Curwin et al.15 followed a patient with an ICD who had
right upper extremity TENS for 16 sessions but then
experienced an inappropriate shock when the electrodes
were moved. ICD intracardiac electrograms conﬁrmed
normal sinus rhythm, with additional high-frequency
signals, prompting discharge at the time. They suggest
that orientation of the TENS electrodes may be import-
ant in preventing EMI and that the balance of beneﬁt
and harm should be weighed on an individual basis.
Engelhardt et al.16 described a case of pacemaker
inhibition during shoulder surgery in response to a
peripheral nerve electrical stimulator. The size of shoul-
der muscle contraction guided placement of local
anaesthetic for regional anaesthesia as the stimulating
catheter was advanced towards the nerves of the bra-
chial plexus. An interscalene brachial plexus stimulat-
ing catheter was used. A current of 1.4mA, pulse
duration 1ms, and frequency 2Hz resulted in immedi-
ate bradycardia which resolved as the current was
decreased. An absence of pacing spikes was also
noted on the ECG, followed by normal pacemaker
function as the current was decreased.
Glotzer et al.17 described an ICD patient (abdom-
inal, epicardial bipolar leads) who experienced an
inappropriate discharge in response to electrical
muscle stimulation (60Hz, asymmetrical biphasic
wave, 0–25V) of the lower back. The intracardiac elec-
trogram revealed normal sinus rhythm, whilst the
timing channel sensed electrical activity at 152ms inter-
vals, resulting in a shock delivery. The second patient
with an ICD (subpectoral, endocardial bipolar sensing
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leads) received electrical muscle stimulation (0–100mA
at 300 ms pulse width, 50Hz) to the left forearm, left
shoulder, left upper back, left upper abdomen, and
back. The ICD intracardiac electrogram and marker
channel was monitored continuously throughout the
stimulation. There was no evidence of inappropriate
sensing by the ICD. The authors suggest that there
may be a lower risk of EMI with endocardial leads,
although more data are needed. They also recommend
deactivating ICDs before electrical muscle stimulation
at any site on the body.
Nagele and Azizi18 report the case of a patient with
an ICD who received an inappropriate shock whilst
having TENS (40mA, 50Hz) of the lumbar region.
ICD interrogation revealed false VF. The authors con-
clude that devices for ES should not be used in patients
with pacemakers or deﬁbrillators.
Philbin et al.19 describe a patient who had an
inappropriate ICD shock in response to TENS (loca-
tion of electrodes not described). Device interrogation
revealed sinus rhythm on the intracardiac electrogram
that was interpreted as VF on the disclosure channel.
The authors suggest that an ICD should be considered
a relative contraindication to TENS.
Pyatt et al.20 describe a patient who had a pacing
ICD device and developed bradycardia with the appli-
cation of TENS (100Hz 20%, pulse duration 200 ms,
delivered in bursts of 7 1ms at a frequency of 2Hz)
over the chest wall. The TENS device was tested for
EMI by altering its frequency, position, and output
whilst monitoring the intracardiac electrogram and
marker signals for sensing problems or artefacts. No
interaction was observed. Six months later the patient
complained about dizziness and bradycardia so the
TENS device was tested for EMI again, using the
same method as before. Testing revealed inappropriate
sensing during a symptomatic episode. Pyatt et al. sug-
gest that despite initial negative testing, patients with a
biventricular ICD should be cautioned about the
potential for device interaction and followed up closely,
retesting for EMI at regular intervals if using TENS.
Siu et al.21 describe the case of a patient with an ICD
(subpectoral, endocardial bipolar leads) receiving an
inappropriate discharge whilst using TENS (1–250Hz,
maximal intensity) to the mid back. On device interro-
gation, there was sinus rhythm and a TENS artefact
which the device interpreted as VF. The authors suggest
that ICD wearers should avoid TENS.
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Figure 2. A summary of studies investigating the safety of ES on patients with pacemakers or ICDs. The blue boxes contain studies
investigating the effect of ES of the lower limb. They all conclude that ES is likely to be safe in patients with pacemakers and ICDs. The
red boxes represent studies where ES caused EMI and all of which involved ES above the lower limb. Case studies are to the left of the
picture and safety studies are on the right. Functional interventions are those resulting in motor activation, whereas therapeutic
interventions do not.
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Street et al.22 carried out a cohort study investigating
the training eﬀect of FES on the lower limb in 133 stroke
patients. Two participants had implanted pacemakers
and underwent pacemaker monitoring whilst FES was
set up. No EMI was detected at set up and there were no
adverse events reported in the 20-week follow-up period.
Vlay23 describe a case of inappropriate ICD dis-
charge in response to sacral TENS stimulation 12 in.
away from the ICD pulse generator. The patient had no
symptoms leading up to the discharge. ICD interroga-
tion revealed a sinusoidal wave that was misinterpreted
by the ICD. The authors suggest that ICD patients
should be instructed to avoid TENS.
Wayar et al.24 report two consecutive cases where
patients with subpectoral ICDs experienced interfer-
ence when using NMES for abdominal training (5.0–
11.0V, 7.3–10mA, 55–75Hz/biphasic), resulting in
inappropriate shock delivery. On ICD interrogation,
EMI was incorrectly interpreted as a shockable
rhythm. The authors conclude that abdominal muscle
stimulation should be avoided by patients with an ICD.
Discussion
The risk of utilising lower limb FES for drop foot in
patients with pacemakers and ICDs is unclear. This is
because there are few studies to date that investigate the
use of ES in patients with pacemakers and ICDs, only
one of which included patients using FES for drop
foot.22 Several studies investigated the safety of apply-
ing NMES to the thigh in order to improve muscle
strength and endurance capacity; whilst others exam-
ined TENS of the torso and lower extremity. However,
there is likely to be a number of systematic diﬀerences
between these interventions and applying FES for drop
foot, such as the location of the electrodes, stimulation
parameters, and duration of treatment.
Although the case reports and safety studies cannot
be used to identify the risk of FES for drop foot in
patients with pacemakers and ICDs, they do suggest
that the location of the electrodes is a susceptibility
factor for EMI. For instance, all but one of the studies
in which ES caused EMI involved applying ES to the
torso and upper extremity. In contrast, safety studies
where ES was applied to the lower extremity concluded
that ES is probably safe. However, EMI cannot be
ruled out when ES is applied to the lower extremity,
as demonstrated by Crevenna et al.7 who deliberately
used a low-frequency (3–4Hz) triangular waveform ES
to the thigh in order to mimic VT waveforms. Although
this did induce EMI, very low-frequency ES is generally
not used in clinical practice so Crevenna et al.7 con-
clude that NMES can be applied safely to ICD patients
so long as standard waveforms and frequencies are used
and patients are monitored during the initial ES set-up.
Figure 2 is a summary of the electrode positions used in
studies investigating the eﬀect of ES on ICDs and
pacemakers.
Although several lower extremity safety studies con-
cluded that NMES of the thigh is probably safe, these
investigations are all limited by small participant num-
bers. The largest safety study investigating lower
extremity ES included 27 patients.13 A much larger
sample size is needed to exclude the risk of EMI. In
order to demonstrate that risk of EMI is less than
one in 100 using the rule of threes, for example, a
safety study involving 300 participants and no adverse
events would be required.25 Such a study is yet to be
undertaken. The safety studies that have been con-
ducted could not be combined to produce a summary
statistic because of divergent interventions, outcome
measures, and durations of treatment. The type of ES
was variable, often poorly deﬁned, and in many cases
the stimulation parameters were not fully detailed. The
Table 2. Included case studies.
Study Intervention Location of simulation Patient Outcome
Curwin et al.15 Therapeutic Upper extremity ICD Inappropriate shock
Engelhardt et al.16 Functional Upper extremity Pacemaker Bradycardia
Glotzer et al.17 Functional Torso ICD Inappropriate shock
Nagele and Azizi18 Therapeutic Torso ICD Inappropriate shock
Philbin et al.19 Therapeutic Not known ICD Inappropriate shock
Pyatt et al.20 Therapeutic Torso ICD Dizziness, bradycardia
Siu et al.21 Therapeutic Torso ICD Inappropriate shock
Street et al.22 Functional Lower extremity Pacemaker (n¼ 2) No EMI or adverse events
Vlay23 Therapeutic Torso ICD Inappropriate shock
Wayar et al.24 Functional Torso ICD (n¼ 2) Inappropriate shock
EMI: electromagnetic interference; ICD: implantable cardioverter defibrillator.
Functional interventions are those resulting in a muscle contraction whereas therapeutic interventions do not.
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outcome measures varied from patient-reported
adverse events to real time monitoring of intrinsic car-
diac rhythm and marker channel (Table 1). The dur-
ation of the safety studies also varied from a single
session of ES to using the device for 4 h every day for
12 weeks.9 Due to the small sample sizes and diverse
range of interventions, it is not possible to give a
numerical estimate of the risk of EMI between ES
and pacemakers or ICDs.
Cenik et al.26 conducted a systematic review of the
literature to investigate the safety of NMES for
increasing exercise capacity and reducing cardiac cach-
exia in patients with bipolar ICDs. They included in
their results original articles, safety studies, and case
studies relating to NMES and EMI in ICDs. They
excluded pacemakers and TENS from their search.
The outcome of interest was EMI deﬁned as over-sen-
sing or inappropriate shocks. They identiﬁed four stu-
dies with the full text published in English or
German,7,9,13,24 all of which were included in this
review. Cenik et al. concluded that NMES can be
applied to the thigh and gluteal muscles in ICD
patients if the individual risks of pacemaker malfunc-
tion are acceptable before starting NMES, patients are
compliant, the treatment is regularly supervised by a
doctor, and the ICD device is examined for evidence
of EMI after ﬁrst use. They suggest that large sample
sizes are needed to identify the risk of adverse eﬀects.
We not only included patients with diﬀerent types
of ES but also included studies investigating pace-
makers. This is important because a pacemaker and
ICD is often combined in one unit for people who
need both.
Conclusion
This systematic review indicates that FES for drop
foot could be considered safe in patients with pace-
makers and ICDs. Several short-term safety studies
investigating lower limb NMES have concluded that
it is safe to use in patients with pacemakers and
ICDs; and there have been no case studies describing
EMI when ES is applied to the lower limb. However,
a deﬁnitive safety study that is intervention speciﬁc,
long term, and high powered is needed to identify the
exact risk. Until such a study is realised, FES should
be used with caution in patients with pacemakers and
ICDs. We recommend that pacemaker and ICD func-
tion should be monitored for EMI when ES is ﬁrst
used.
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